Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient (Q30422593)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Weibin Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Aizhong Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yi Miao

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Shengli Xia

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Zhiyang Ling

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Ke Xu

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Tongyan Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Ying Xu

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jun Cui

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Hongqiang Wu

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Guiyu Hu

11

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Lin Tian

12

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Lingling Wang

13

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yuelong Shu

14

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiaowei Ma

15

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Bianli Xu

16

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jin Zhang

17

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiaojun Lin

18

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Chao Bian

19

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Bing Sun

20

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

16 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

435

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

320-328

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Antibody recognition of a highly conserved influenza virus epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A highly conserved neutralizing epitope on group 2 influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A novel mechanism for the acquisition of virulence by a human influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Influenza: old and new threats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/23084424

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIROL.2012.09.034

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30422593&oldid=1976121902"